Skip to main content
SpringerLink
Log in

Reproductive Aging: Epidemiology, Symptomatology, and Nomenclature

  • Chapter
  • First Online:
Essentials of Menopause Management

Abstract

Aging-related decline in the endocrine and procreative functions of ovaries is the norm, and menopause is the stage of life that is characterized by an eventual cessation of these respective functions. While menopause, as puberty, represents a physiological state, as with puberty, this phase of life may be more challenging for some than others. In this introductory chapter of a textbook on Menopause, our goal is to set the stage, familiarizing the readers with the players (reproductive hormones), the scenes (spectrum of symptoms commonly experienced by women as they approach and enter a new innings of life), and the plot (long-term implications of reproductive senescence).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas. 1981;3:249–64.

    Article  CAS  PubMed  Google Scholar 

  2. Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nation. Am J Public Health. 2006;96:1226–35.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Thurston RC, Bromberger JT, Joffe H, Avis NE, Hess R, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause. 2008;15:841–7.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175:531–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nedstrand E, Wijma K, Lindgren M, Hammar M. The relationship between stress-coping and vasomotor symptoms in postmenopausal women. Maturitas. 1998;31:29–34.

    Article  CAS  PubMed  Google Scholar 

  6. Reynolds F. Relationships between catastrophic thoughts, perceived control and distress during menopausal hot flushes: exploring the correlates of a questionnaire measure. Maturitas. 2000;36:113–22.

    Article  CAS  PubMed  Google Scholar 

  7. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, et al. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause. 2005;12:258–66.

    Article  PubMed  Google Scholar 

  8. Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) – results from an international survey. Climacteric. 2012;15:36–44.

    Article  CAS  PubMed  Google Scholar 

  9. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–8.

    CAS  PubMed  Google Scholar 

  10. Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V. Clarifying vaginal Atrophy’s impact on sex and relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause. 2014;21:137–42.

    Article  PubMed  Google Scholar 

  11. Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (real women’s views of treatment options for menopausal vaginal changes) survey. J Sex Med. 2013;10:1790–9.

    Article  PubMed  Google Scholar 

  12. Barlow DH, Cardozo LD, Francis RM, Griffin M, Hart DM, et al. Urogenital aging and its effect on sexual health in older Brittish women. Br J Obstet Gynecol. 1997, 104: 87–91.

    Google Scholar 

  13. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6:2133–42.

    Article  PubMed  Google Scholar 

  14. Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas. 1990;12:51–60.

    Article  CAS  PubMed  Google Scholar 

  15. Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21:450–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. J Sex Med. 2014;11:2865–72.

    Article  PubMed  Google Scholar 

  17. Bruyniks N, Nappi RE, Castelo-Branco C, de Villiers TJ, Simon J. Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric. 2015;19:1–6.

    Google Scholar 

  18. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10:19–28.

    PubMed  Google Scholar 

  19. Freeman EW, Sammel MD, Gross SA, Pien GW. Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause. 2015;22:719–26.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ensrud KE, Stone KL, Blackwell TL, Sawaya GF, Tagliaferri M, et al. Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause. 2009;16:286–92.

    Article  PubMed  Google Scholar 

  21. Joffe H, White DP, Crawford SL, McCurnin KE, Economou N, et al. Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol. Menopause. 2013;20:905–14.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kravitz HM, Zhao X, Bromberger JT, Gold EB, Hall MH, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31:979–90.

    PubMed  PubMed Central  Google Scholar 

  23. Thurston RC, Santoro N, Matthews KA. Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause. 2012;19:742–8.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril. 2004;82:138–44.

    Article  PubMed  Google Scholar 

  25. Blumel JE, Cano A, Mezones-Holguin E, Baron G, Bencosme A, et al. A multinational study of sleep disorders during female mid-life. Maturitas. 2012;72:359–66.

    Article  PubMed  Google Scholar 

  26. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–14.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–92.

    Article  PubMed  Google Scholar 

  28. Bjorvatn B, Leissner L, Ulfberg J, Gyring J, Karlsborg M, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med. 2005;6:307–12.

    Article  PubMed  Google Scholar 

  29. Hogl B, Kiechl S, Willeit J, Saletu M, Frauscher B, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology. 2005;64:1920–4.

    Article  CAS  PubMed  Google Scholar 

  30. Manconi M, Ulfberg J, Berger K, Ghorayeb I, Wesstrom J, et al. When gender matters: restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group. Sleep Med Rev. 2012;16:297–307.

    Article  PubMed  Google Scholar 

  31. Buysse DJ. Insomnia. JAMA. 2013;309:706–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA. 2003;289:3095–105.

    Article  PubMed  Google Scholar 

  33. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci. 2008;33:331–43.

    PubMed  PubMed Central  Google Scholar 

  34. Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71:36–43.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385–90.

    Article  PubMed  Google Scholar 

  36. Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women’s Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010;67:598–607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, et al. A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry. 2008;69:973–80.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62–70.

    Article  CAS  PubMed  Google Scholar 

  39. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63:375–82.

    Article  CAS  PubMed  Google Scholar 

  40. Georgakis MK, Thomopoulos TP, Diamantaras AA, Kalogirou EI, Skalkidou A, et al. Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73:1–12.

    Article  Google Scholar 

  41. Li L, Wu J, Pu D, Zhao Y, Wan C, et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas. 2012;73:354–60.

    Article  PubMed  Google Scholar 

  42. Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for menopause rating scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Womens Health. 2011;11:30.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Blumel JE, Chedraui P, Baron G, Belzares E, Bencosme A, et al. Menopause could be involved in the pathogenesis of muscle and joint aches in mid-aged women. Maturitas. 2013;75:94–100.

    Article  PubMed  Google Scholar 

  44. El Shafie K, Al Farsi Y, Al Zadjali N, Al Adawi S, Al Busaidi Z, et al. Menopausal symptoms among healthy, middle-aged Omani women as assessed with the menopause rating scale. Menopause. 2011;18:1113–9.

    Article  PubMed  Google Scholar 

  45. Olaolorun FM, Lawoyin TO. Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause. 2009;16:822–30.

    Article  PubMed  Google Scholar 

  46. Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, et al. Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial. Menopause. 2013;20:600–8.

    Article  PubMed  Google Scholar 

  47. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:387–95.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012;97:843–51.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15:105–14.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97:1159–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Rossmanith WG, Ruebberdt W. What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol. 2009;25:303–14.

    Article  PubMed  Google Scholar 

  52. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20:888–902; quiz 903–884.

    Google Scholar 

  53. Winneker RC, Harris HA. Progress and prospects in treating postmenopausal vaginal atrophy. Clin Pharmacol Ther. 2011;89:129–32.

    Article  CAS  PubMed  Google Scholar 

  54. Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67:233–8.

    Article  PubMed  Google Scholar 

  55. Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause. 2008;15:661–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Montefiore Medical Center/Albert Einstein College of Medicine, 1300 Morris Park Avenue, Block building 6th Floor, Room 627, Bronx, NY, 10461, USA

    Satu Kuokkanen MD, PhD

  2. Yale School of Medicine, 33 Cedar Street, 208063, New Haven, CT, 06510, USA

    Lubna Pal MBBS, FRCOG, MS, FACOG

Authors
  1. Satu Kuokkanen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lubna Pal MBBS, FRCOG, MS, FACOG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satu Kuokkanen MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility Yale School of Medicine, New Haven, Connecticut, USA

    Lubna Pal

  2. Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA

    Raja A. Sayegh

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kuokkanen, S., Pal, L. (2017). Reproductive Aging: Epidemiology, Symptomatology, and Nomenclature. In: Pal, L., Sayegh, R. (eds) Essentials of Menopause Management. Springer, Cham. https://doi.org/10.1007/978-3-319-42451-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42451-4_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42449-1

  • Online ISBN: 978-3-319-42451-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation